Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's SyndromeSimon Bowman, Colin Everett, John O’Dwyer et al.|Arthritis & Rheumatology|2017Cited by 269
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal CancerPeter S Hall, Pavel Bezecny, Sebastian Cummins et al.|JAMA Oncology|2021Cited by 196
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudyBenjamin A. Fisher, Simon Bowman, Colin Everett et al.|Annals of the Rheumatic Diseases|2017Cited by 109
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster et al.|The Lancet Oncology|2025Cited by 23
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, David Sebag‐Montefiore, Alexandra Gilbert et al.|BMJ Open|2025Cited by 8